Skip to main content
SLDBHealthcare

Solid Biosciences Inc (SLDB) Insider Trading

In the last 90 days, 1 Solid Biosciences Inc (SLDB) insider reported no open-market purchases and 1 sale totaling $24,582. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 19, 2026Gabriel BrooksChief Medical OfficerSale4,374$5.62$24,582

Common questions

SLDB insider trading FAQ

Are SLDB insiders buying or selling?
Over the last 90 days, SLDB insiders were net sellers, reporting $0.00 of open-market purchases and $24,582 of sales.
When was the last SLDB insider purchase?
No open-market insider purchase of Solid Biosciences Inc stock was reported in the last 90 days.
Where does SLDB insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Solid Biosciences Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.